Medical technology firm Medtronic has introduced new lung tissue biopsy tool, GenCut core biopsy system, which can be used with the superDimension navigation system.
The superDimension system helps in accessing difficult-to-reach areas of the lung, assisting in the diagnosis of lung cancer.
Pulmonologists and thoracic surgeons can use the new GenCut core biopsy system to collect multiple core samples from lesions deep inside the lungs.
Featuring proprietary blade design, the system can shear and collect more intact samples, allowing physicians to provide the pathology laboratory with tissue that enables cytology.
Medtronic Minimally Invasive Therapies Group, early technologies president Chuck Brynelsen said: "Lung cancer diagnostic clinicians consistently state that tissue is the issue. When performing a biopsy, they need enough tissue for the pathologist to make a diagnosis and to ensure undamaged tissue for genetic testing and molecular analysis.
"As lung cancer drugs and therapies advance, the ability to provide earlier diagnosis and earlier, personalized treatment can potentially save lives."
In April this year, the GenCut core biopsy system obtained 510(k) approval from the US Food and Drug Administration.
Image: Medtronic’s lung tissue biopsy tool, GenCut core biopsy system. Photo: courtesy of Medtronic plc.